Stonekeep Investments’s AbbVie ABBV Stock Holding History

Stonekeep Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$215K	Hold	823	–	–	0.13%	72
2026 Q2	$207K	Buy	+823	New	+$177K	0.12%	76

Other funds holding ABBV

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Stonekeep Investments's ABBV Position: Q3 2026 in Review

Stonekeep Investments held its AbbVie (ABBV) position steady in Q3 2026 at 823 shares worth $215K. The position accounts for 0.13% of the portfolio, ranked #72.

Stonekeep Investments first reported a position in ABBV in Q2 2026 and has held it in 2 quarters since. 2,330 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Stonekeep Investments held 823 shares of AbbVie worth $215K as of Q3 2026.
Stonekeep Investments left its AbbVie share count unchanged in Q3 2026.
AbbVie made up 0.13% of Stonekeep Investments's portfolio in Q3 2026, its #72 holding.
Stonekeep Investments first reported a position in AbbVie in Q2 2026 and has held it in 2 quarters since.
2,330 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Stonekeep Investments's 13F filing for Q3 2026, filed 15 Oct 2026.